Benefits and Harms of Benign Prostatic Obstruction Treatments in Renal Transplanted Patients

Zakri, Rhana Hassan; Hevia, Vital; Bossier, Romain; Rodríguez-Faba, Óscar; García, E. Lledó; Budde, Klemens; Breda, Alberto; Olsburgh, Jonathon; Figueiredo, Arnaldo

doi:10.1016/j.euf.2023.05.001

European Urology Focus

2023

DOI: 10.1016/j.euf.2023.05.001

|View full text |Cite

Benefits and Harms of Benign Prostatic Obstruction Treatments in Renal Transplanted Patients

Rhana Hassan Zakri¹,

Vital Hevia²,

Romain Bossier³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Prevalence of non‐neurogenic male lower urinary tract symptoms after kidney transplantation

Costa Silva,

Pina‐Vaz,

Morgado

et al. 2024

BJU International

View full text Add to dashboard Cite

ObjectiveThis review investigates the prevalence of male non‐neurogenic lower urinary tract symptoms (LUTS) after renal transplant, as kidney transplantation is a transformative intervention for patients with end‐stage renal disease significantly enhancing quality of life that might be diminished by LUTS.MethodsThe Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines were followed. A systematic search in the PubMed and Scopus databases was performed using specific terms. Inclusion criteria considered male kidney transplant recipients, analysing outcomes in English‐language studies. Discrepancies were resolved by consultation.ResultsAmong 18 studies involving 29 086 recipients, the prevalence of non‐neurogenic LUTS ranged from 5.8% to 33.0%. Studies predominantly used the International Prostate Symptom Score for evaluation. Surgical interventions, mostly for benign prostatic obstruction, ranged from 2.5% to 20.0%. Voiding and post‐micturition symptoms were under‐represented.ConclusionThis review found varied non‐neurogenic LUTS prevalence and characteristics in male kidney transplant recipients, emphasising the need for standardised assessments, prospective studies, and improved understanding of LUTS mechanisms. Enhanced knowledge can guide interventions, additionally benefiting recipient quality of life.

show abstract

Prevalence of non‐neurogenic male lower urinary tract symptoms after kidney transplantation

Costa Silva,

Pina‐Vaz,

Morgado

et al. 2024

BJU International

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Benefits and Harms of Benign Prostatic Obstruction Treatments in Renal Transplanted Patients

Cited by 1 publication

References 15 publications

Prevalence of non‐neurogenic male lower urinary tract symptoms after kidney transplantation

Prevalence of non‐neurogenic male lower urinary tract symptoms after kidney transplantation

Contact Info

Product

Resources

About